MAXCELL financials
A multi-period view of the public annual-account figures reported for MAXCELL, with comparable measures and links to available source documents.
Company overviewRegistry number
0880352402
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for MAXCELL
2025 versus 2024
- Operating line
- €42,597
- EBITDA
- €40,382
- Total assets
- €123,886
- Equity
- €89,392
-19.9%
-19.6%
-13.1%
+11.3%
EBITDA margin +94.8% · Equity ratio +72.2%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €42,597 | €40,382 | €123,886 | €89,392 | - |
| 202431 Dec 2024 | €53,200 | €50,201 | €142,501 | €80,320 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.